Cited by 561Ovarian function and disordersMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Open access

Dunaif, A, Xia, J, Book, C B, Schenker, E, Tang, Z·1995·Journal of Clinical Investigation

DOI 10.1172/jci118126PMC PMC185266

Open this paper in CoChat — free account Open PDF

Abstract

We investigated the cellular mechanisms of the unique disorder of insulin action found in the polycystic ovary syndrome (PCOS). Approximately 50% of PCOS women (PCOS-Ser) had a significant increase in insulin-independent beta-subunit [32P]phosphate incorporation (3.7-fold, P < 0.05 vs other groups) in skin fibroblast insulin receptors that was present in serine residues while insulin-induced tyrosine phosphorylation was decreased (both P < 0.05 vs other groups). PCOS skeletal muscle insulin receptors had the same abnormal phosphorylation pattern. The remaining PCOS women (PCOS-n1) had basal and insulin-stimulated receptor autophosphorylation similar to control. Phosphorylation of the artificial substrate poly GLU4:TYR1 by the PCOS-Ser insulin receptors was significantly decreased (P < 0.05) compared to control and PCOS-n1 receptors. The factor responsible for excessive serine phosphorylation appeared to be extrinsic to the receptor since no insulin receptor gene mutations were identified, immunoprecipitation before autophosphorylation corrected the phosphorylation defect and control insulin receptors mixed with lectin eluates from affected PCOS fibroblasts displayed increased serine phosphorylation. Our findings suggest that increased insulin receptor serine phosphorylation decreases its protein tyrosine kinase activity and is one mechanism for the post-binding defect in insulin action characteristic of PCOS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci118126

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L., Dull, T. J., Gray, A., Coussens, L. M., Liao, Y.-C., Tsubokawa, M., et al. (1985) · Nature · doi:10.1038/313756a0 · Cited by 2,251
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Self-citation
Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity.
Ullrich, A., Gray, A., Tam, A. W., Yang‐Feng, T. L., Tsubokawa, M., Collins, C. M., Henzel, W. J., Bon, T. L., Kathuria, S., & Chen, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04528.x · Cited by 1,843
[42] Detection and quantification of phosphotyrosine in proteins
Cooper, J. A., Sefton, B. M., & Hunter, T. R. (1983) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(83)99075-4 · Cited by 1,109
Prevalence of Diabetes and Impaired Glucose Tolerance and Plasma Glucose Levels in U.S. Population Aged 20–74 Yr
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Insulin Action, Diabetogenes, and the Cause of Type II Diabetes
Kahn, C. R. (1994) · Diabetes · doi:10.2337/diab.43.8.1066 · Cited by 916
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
POLSON, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 899
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624

Show all 71 references

Sorted by citations

Items 401–500 of 559

Polymorphism in postinsulin receptor signaling pathway is not associated with polycystic ovary syndrome
Jones, M. R., Wilson, S. G., Mullin, B. H., Mead, R., Dudbridge, F., Watts, G. F., & Stuckey, B. G. A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.10.079 · Cited by 6
Die Insulinresistenz beim polyzystischen Ovar-Syndrom
Schröder, A. K., Tauchert, S., Ortmann, O., Diedrich, K., & Weiss, J. M. (2003) · Wiener klinische Wochenschrift · doi:10.1007/bf03041041 · Cited by 6
Endocrine and Metabolic Effects of Insulin Sensitizers in the Treatment of Patients with Polycystic Ovary Syndrome and Hyperinsulinaemia
Ciotta, L., Leo, V. D., Farina, M., Pafumi, C., Marca, A. L., & Cianci, A. (2001) · Gynecologic and Obstetric Investigation · doi:10.1159/000052890 · Cited by 6
The Role of Gene Alterations in the Pathogenesis of Polycystic Ovary Syndrome
Carmina, E. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14103347 · Cited by 5
A review on inositol’s potential in cyclic disturbances of adipose-endocrinology-associated polycystic ovary syndrome
Almalki, W. H. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04123-3 · Cited by 5
Polycystic ovarian syndrome and insulin resistance: a North Indian study
Agarwal, N., Gangopadhyay, S., Koch, N., Gupta, A., Batra, A., & Kabi, B. C. (2015) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20150139 · Cited by 5
Endocrine and metabolic changes in women with polycystic ovaries and polycystic ovary syndrome
Koivunen, R. M. (2001) · Cited by 5
PCOS Modulatory Activity of Tinospora cordifolia leaves – An Insilico Approach
Devi, M. S., Muralidharan, P., Hari, R., Lavanya, M., & Abiraamavalli, T. A. (2021) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2215 · Cited by 5
[Retracted] Effects of Different Ovulation Induction Regimens on Sex Hormone Levels and Serum CTRP3 and CTRP15 Levels in Patients with Polycystic Ovary Syndrome (PCOS)
Ren, M., Liu, J., Zhang, Y., & Fan, L. (2022) · BioMed Research International · doi:10.1155/2022/6027878 · Cited by 5
Retracted
Polycystic ovarian syndrome: Assessment of approaches to diagnosis and cardiometabolic monitoring in UK primary care
Heald, A. H., Livingston, M. A., Holland, D., Robinson, J. C., Moreno, G. Y., Donnahey, G., Duff, C. J., Wu, P., & Fryer, A. A. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.13046 · Cited by 5
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4907-4.00020-6 · Cited by 5
Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
Bellanger, S., Battista, M., & Baillargeon, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_7 · Cited by 5
Identification of follistatin as a possible trait-causing gene in polycystic ovary syndrome
Asteria, C. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430467 · Cited by 5
Polycystic Ovary Syndrome
Zweig, S. B., Tolentino, M. C., Strizhevsky, M., & Poretsky, L. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_33 · Cited by 5
The Polycystic Ovary Syndrome Pathogenesis, Metabolic Implications, and Therapeutic Approach
Diamanti‐Kandarakis, E. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52142.x · Cited by 5
Membrane glycoprotein PC-1 and insulin resistance
Goldfine, I. D., Maddux, B. A., YOUNGREN, J. F., Frittitta, L., Trischitta, V., & Dohm, G. L. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5647-3_19 · Cited by 6
The Endocrinological Basis for Polycystic Ovary Syndrome: An Evolutionary Perspective
Dumesic, D. A., Crespi, B. J., Padmanabhan, V., & Abbott, D. H. (2025) · Endocrinology · doi:10.1210/endocr/bqaf160 · Cited by 4
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00022-6 · Cited by 4
Implementing Neural Fuzzy Rough Set and Artificial Neural Network for Predicting PCOS
Meena, K., Manimekalai, M. A. P., & Rethinavalli, S. (2015) · International Journal on Recent and Innovation Trends in Computing and Communication · doi:10.17762/ijritcc.v3i12.5128 · Cited by 4
Plymorphism of CYP17 for Polycystic Ovarian Syndrome in Women of Salah Al-Din Provence/ Iraq
Omear, H. A., Shehab, A. F., & Al-Assie, A. H. A. (2014) · Journal of Biotechnology Research Center · doi:10.24126/jobrc.2014.8.1.305 · Cited by 4
Subclinical inflammation in obese women with polycystic ovary syndrome
Elkholi, D. G. E. Y., & Hammoudah, S. F. (2012) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2012.02.004 · Cited by 4
Natural Approaches for Treating Polycystic Ovary Syndrome
Meletis, C. D., & Zabriskie, N. (2006) · Alternative and Complementary Therapies · doi:10.1089/act.2006.12.157 · Cited by 4
Human Chorionic Gonadotropin Stimulation to Assess for Ovarian Hyperandrogenism
Witchel, S. F., & Lee, P. A. (1998) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/s1083-3188(98)70115-9 · Cited by 4
CXC Ligand 5 cytokine serum level in women with polycystic ovary syndrome and normal body mass index: A case-control study
Zohrabi, M., Rahmani, E., Motamed, N., & Akbarzadeh, S. (2017) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.15.10.4 · Cited by 4
Evaluation of the Clinical, Endocrinological, and Biochemical Differences Between Adolescent and Adult Patients with Polycystic Ovary Syndrome
Yüce, E., Pabuçcu, R., Keskin, M., Arslanca, T., & Pabuçcu, E. (2020) · Türk Üreme Tıbbı ve Cerrahisi Dergisi · doi:10.24074/tjrms.2020-80616 · Cited by 4
Disorders of carbohydrate metabolism in women with polycystic ovary syndrome (PCOS)
Dardzińska, J. A., Kuligowska-Jakubowska, M., & Rachoń, D. (2012) · Via Medica Journals · Cited by 4
Research progress on insulin resistance in polycystic ovary syndrome
Qi, Y.-B., Yi, P., & Fu, X. (2025) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000131 · Cited by 5
Vitamin D in Endocrine Disorders: A Broad Overview of Evidence in Musculoskeletal, Thyroid, Parathyroid, and Reproductive Disorders
Lengyel, B., Armos, R., Bojtor, B., Kiss, A., Tóbiás, B., Pikó, H., Illés, A., Horvath, E. M., Putz, Z., Takács, I., et al. (2025) · Pharmaceuticals · doi:10.3390/ph19010054 · Cited by 3
Botanical Treatment for Polycystic Ovary Syndrome
Kasim-Karakas, S. E., & Mishra, S. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374228-5.00015-9 · Cited by 3
Criteria for the diagnosis of metabolic syndrome: A review
Ogbu, I. S. I. (2023) · Journal of Medical Laboratory and Diagnosis · doi:10.5897/jmld2022.0174 · Cited by 3
Role of hyperinsulinemic insulin resistance in polycystic ovary syndrome
Iuorno, M. J. (2001) · Polycystic Ovary Syndrome · doi:10.1017/cbo9780511545191.013 · Cited by 3
Effect of Vitamin E on Polycystic Ovary Syndrome Induced by Dehydroepiandrosterone in Female Albino Mice: Histological Study
Aburawi, S. M., Treesh, S. A., Jaafari, H. E., Elghedamsi, M. T., Nafati, N. A., Benmahmoud, O. A., Almajry, M., & Shebani, N. (2021) · Malaysian Journal of Pharmaceutical Sciences · doi:10.21315/mjps2021.19.2.8 · Cited by 3
Pathogenesis and Management of Adiposity and Insulin Resistance in Polycystic Ovary Syndrome (PCOS)
Barber, T. M., Joharatnam, J., & Franks, S. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_36 · Cited by 3
The Efficacy of Metformin Treatment on Insulin Resistance and Hyperandrogenism in Lean Women with Polycystic Ovary Syndrome: A Literature Review
Gu, R., & Syed, N. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.417 · Cited by 3
Le syndrome des ovaires polymicrokystiques
Robin, G., Catteau-Jonard, S., Proust-Richard, C., Decanter, C., & Dewailly, D. (2012) · Elsevier eBooks · doi:10.1016/b978-2-294-70154-2.00013-3 · Cited by 4
STUDY OF ADOLESCENT GIRLS WITH MENSTRUALIRREGULARITIES FOR POLYCYSTIC OVARIES AND INSULIN RESISTANCE
Kumari, S., Pankaj, S., Kavita, K., Choudhary, V., & Raghwendra, K. H. (2015) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2015/802 · Cited by 3
Polycystic ovary syndrome: the present position
Jacobs, H. S. (1996) · Gynecological Endocrinology · doi:10.3109/09513599609023608 · Cited by 3
Deciphering polycystic ovary syndrome: A brief overview from metabolic drivers to genetic and fetal origins
Morales-Esponda, M., Aguilar, R. D. L. S., Villanueva-Rodríguez, R., Oliva, L. D. S., Aguilar-Salinas, C. A., Chirinos, M., & Larrea, F. (2025) · Revista de investigaci�n Cl�nica · doi:10.1016/j.ric.2025.100008 · Cited by 2
Metformin-loaded Chitosan nanoparticles alleviate insulin resistance in the polycystic ovarian syndrome rat model through modulation of PI3K/AKT/ GLUT4 in ovarian tissue
Issa, S. M., Thabet, E. H., Dief, A. E., Omar, W. E., Saleh, S. R., Essawy, M. M., & Eter, E. A. E. (2025) · Reproductive Biology · doi:10.1016/j.repbio.2025.101081 · Cited by 2
The pediatric origins of polycystic ovary syndrome
Roldán, B., & Escobar-Morreale, H. F. (2001) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545191.015 · Cited by 2
DHT and Insulin Upregulate Secretion of the Soluble Decoy Receptor of IL-33 From Decidualized Endometrial Stromal Cells
Salamon, D., Ujvári, D., Hellberg, A., & Hirschberg, A. L. (2023) · Endocrinology · doi:10.1210/endocr/bqad174 · Cited by 2
The frequency of metabolic syndrome in patients with acrochordons
Kurtipek, G. S., Duran, C., Kutlu, O., Ataseven, A., Akyürek, F. T., Kurku, H., & Elmas, H. (2017) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v16i1.31130 · Cited by 2
Pattern of Common Hormonal Disorders among Patients with Polycystic Ovarian Syndrome at a Tertiary Health Facility in Nigeria
Oladosu, W., Jimoh, O. S., Adeniyi, W. A., Alayo, A. M., Ahmed, A. O., Raji-Olarinoye, S. T., Ajadi, T. A., & Biliaminu, S. A. (2022) · Nigerian Journal of Medicine · doi:10.4103/njm.njm_190_21 · Cited by 2
Comparison of the Effectiveness and Safety of Myo Inositol with Metformin for the Treatment of Polycystic Ovary Syndrome in Women
Wazir, S., Rahman, F., Bibi, R., Tariq, H., Farooqi, K., & Afridi, N. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22168926 · Cited by 2
Reproduction and Metabolism: Insights from Polycystic Ovary Syndrome
Jasti, P., & Dunaif, A. E. (2012) · Endocrinology and Metabolism · doi:10.3803/enm.2012.27.3.180 · Cited by 2
Self-citation
Kontrowersje wokół patogenezy zespołu policystycznych jajników
Szydlarska, D., Grzesiuk, W., & Bar‐Andziak, E. (2010) · Via Medica Journals · Cited by 2
The multifarious role of insulin in PCOS: From pathophysiology to therapeutic management
Moghetti, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00002-x · Cited by 2
Etiopathogenesis
Stracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_2 · Cited by 2
Polycystic Ovary Syndrome and Its Metabolic Complications
Liao, E. P., & Poretsky, L. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_15 · Cited by 2
Metabolic syndrome in patients with the polycystic ovary syndrome
Panidis, D., Τζιόμαλος, Κ., & Papadakis, E. P. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2013.853451 · Cited by 2
Polycystic ovarian syndrome and insulin resistance: a South Indian study
Anuradha, V., Gangadharan, K., Saxena, R. K., & Krishna, L. (2020) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20201054 · Cited by 2
Polycystic Ovarian Syndrome
Dokras, A., & Sivitz, W. I. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-378-1_9 · Cited by 2
Polycystic Ovarian Syndrome
Christou, M., Mintziori, G., Goulis, D. G., & Tarlatzis, B. C. (2023) · ISGE series · doi:10.1007/978-3-031-22378-5_8 · Cited by 2
Metabolic and cardiovascular risk in the polycystic ovary syndrome
Cussons, A. J., Stuckey, B. G. A., & Watts, G. F. (2005) · Practical Diabetes · doi:10.1002/pdi.839 · Cited by 2
Insulin resistance in polycystic ovary syndrome
Morin-Papunen, L. C. (2000) · Cited by 2
Concomitant impact of polycystic ovarian syndrome and associated comorbidities on cognitive functions, neurotransmitters, and metabolic enzymes in Indian womenPreprint
Ananthasubramanian, P., Nair, R. S., Priyanka, H. P., Seetharaman, B., & Vasantharekha, R. (2022) · Research Square · doi:10.21203/rs.3.rs-2063962/v1 · Cited by 2
Insulin Resistance and Hyperinsulinism in the Polycystic Ovary Syndrome
Essah, P. A., & Nestler, J. E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_24 · Cited by 1
Polycystic ovary syndrome and idiopathic central precocious puberty: two sides of the same coin?
Cela, E., Tarantino, C., Vincenzi, L., Tenuta, M., Pozza, C., Minnetti, M., & Sbardella, E. (2025) · Endocrine · doi:10.1007/s12020-025-04461-y · Cited by 1
Ubiquitination of glucose and lipid metabolic proteins is altered in diabetic rat livers
Abo‐Ali, E. M., Shetty, D. K., Khairnar, R., Kumar, S., & Dukhande, V. V. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.124120 · Cited by 1
Insulin Resistance in the Pathophysiology of Polycystic Ovary Syndrome
Chada, S. R., & Sahay, R. K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810931125010014 · Cited by 1
Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks
Mcgowan, M., Cowan, S., Tay, C. T., McGowan, M. Μ., & Ng, A. H. (2026) · Experimental Physiology · doi:10.1113/ep092880 · Cited by 1
Ovarian Dysfunction in Polycystic Ovary Syndrome
Mason, H. D., Dilaver, N., & Rice, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_4 · Cited by 1
Role of Insulin-Sensitizing Drugs in PCOS Management
Awwad, J. T., & Ghazeeri, G. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_10 · Cited by 1
Das polyzystische Ovarsyndrom – Metabolische Konsequenzen
Tan, S., Hahn, S., & Janssen, O. E. (2008) · Gyn�kologisch-geburtshilfliche Rundschau · doi:10.1159/000111466 · Cited by 1
Why can’t a man be more like a mouse?: Reply of the authors
Morán, C., & Azziz, R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02077-5 · Cited by 1
Myoinositol with Metformin and Myoinositol alone in infertile PCOS women undergoing ovulation induction cycles: A comparative study
Gade, P. R., Aher Gautam, S., & Vazifdar, S. (2021) · International Journal of Clinical and Biomedical Research · doi:10.31878/ijcbr.2021.72.02 · Cited by 1
Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences
Carreau, A., Battista, M., & Baillargeon, J. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_8 · Cited by 1
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.37 · Cited by 1
Low-dose spironolactone attenuates metabolic defects in the skeletal muscle of letrozole-induced hyperandrogenic female rats
Areloegbe, S. E. J., Atuma, C. L., Oyabambi, A. O., & Olaniyi, K. S. (2023) · Nutrire · doi:10.1186/s41110-023-00205-y · Cited by 1
A Review of Special Considerations on Insulin Resistance Induced Hyperandrogenemia in Women with Polycystic Ovary Syndrome: A Prominent COVID-19 Risk Factor.
Roozbeh, J., Janfeshan, S., Afshari, A., Doostkam, A., & Yaghobi, R. (2022) · PubMed Central · doi:10.22088/ijmcm.bums.11.2.168 · Cited by 1
Calpain-10 Polymorphism in Korean Women with Polycystic Ovary Syndrome
Lee, H. J., Pyun, G. W., Byun, E. K., Oh, J. Y., Oh, J. Y., Hong, Y.-S., Sung, Y., & Chung, H. W. (2008) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2008.23.5.319 · Cited by 1
Adiponectin and Ghrelin Polymorphism in Korean Women with Polycystic Ovary Syndrome
Lee, H., Byun, E. K., Park, H. R., Oh, J. Y., Hong, Y.-S., Sung, Y., & Chung, H. (2006) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2008.21.5.394 · Cited by 1
Evaluation of insulin resistance in adolescent girl with menstrual irregularities
Kumari, S., Pankaj, S., Sinha, A., Prasad, D., & Kumar, R. (2015) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20151283 · Cited by 1
Reproductive Disorders and Obesity in Males and Females and Focus on the Polycystic Ovary Syndrome
Repaci, A., & Pasquali, R. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_40-1 · Cited by 1
Insulin Resistance in Pediatric Disease
Bremer, A. A. (2012) · Pediatric Annals · doi:10.3928/00904481-20120110-07 · Cited by 1
Polycystic ovarian syndrome: Social situation influences outcome
Livingston, M. A., Holland, D., Kalansooriya, A., Moreno, G. Y., Donnahey, G., Duff, C. J., Wu, P., Fryer, A. A., & Heald, A. H. (2017) · International Journal of Clinical Practice · doi:10.1111/ijcp.12981 · Cited by 1
Bilan avant assistance médicale à la procréation : le versant féminin
Robin, G. (2018) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(18)30211-9 · Cited by 1
Prevalence of cardiovascular diseases and type 2 diabetes mellitus in perimenopausal women with a history of the polycystic ovary syndrome
Popova, P., Baranova, E. V., & Grineva, E. N. (2009) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2009-15-2-218-222 · Cited by 1
Síndrome de ovarios poliquísticos
Robin, G., Peigné, M., Dumont, A., Plouvier, P., Rolland, A.-L., Catteau-Jonard, S., & Dewailly, D. (2020) · EMC - Ginecología-Obstetricia · doi:10.1016/s1283-081x(20)44039-1 · Cited by 1
Role of Insulin-Sensitizing Drugs in PCOS Management
Kojok, D., Ghazeeri, G. S., & Awwad, J. T. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_12 · Cited by 1
Research Progress on the Etiology and Pathogenesis of PCOS-IR and Its Treatment in Chinese and Western Medicine
张, 楚. (2023) · Traditional Chinese Medicine · doi:10.12677/tcm.2023.129374 · Cited by 1
Polycystic Ovary Syndrome and Metabolic Syndrome
Pesant, M.-H., & Baillargeon, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-192-5_14 · Cited by 1
The Risks of Cardiovascular Disease and Diabetes in the Polycystic Ovary Syndrome
Sharma, S. T., & Nestler, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_10 · Cited by 1
Obesity in Polycystic Ovary Syndrome: Two Diseases or One?
Salehi, M., Vera, R. B., Sheikh, A., Gouller, A., & Poretsky, L. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Conceptos básicos sobre infertilidad, incluido el síndrome de poliquistosis ovárica
Brassard, M., Ainmelk, Y., & Baillargeon, J. (2008) · Clínicas médicas de Norteamérica · doi:10.1016/s0186-0194(08)92058-x · Cited by 1
Insulin Resistance and Inhibitors of the Insulin Receptor Tyrosine Kinase
YOUNGREN, J. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_15 · Cited by 1
Genes Related to Metabolic Abnormalities or Insulin Resistance in Polycystic Ovary Syndrome
Escobar-Morreale, H. F. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_5 · Cited by 1
Efecto del clorhidrato de metformina sobre el metabolismo en mujeres con síndrome de ovarios poliquísticos
González-González, F., Nicolau, O., Essien, J., & Mitac, J. B. (2003) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/s0210-573x(03)77235-9 · Cited by 1
Review Article and Clinical Experience: THE ROLES OF MICRONUTRIENTS IN THE TREATMENT OF DIABETES MELLITUS (Focus on Chromium and Specific Nutrients)
Tjokroprawiro, A. (2003) · Folia Medica Indonesiana · Cited by 1
Polycystic ovary syndrome and associated metabolic features in indigenous women in the Northern Territory.
Boyle, J. A. (2011) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Polycystic Ovary Syndrome and the Metabolic Syndrome
Janssen, O. E., Tan, S., Dietz, T., & Hahn, S. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-37 · Cited by 1
Metabolic Alterations in Muscle Associated with Obesity
Thyfault, J. P., & Dohm, G. L. (2005) · CRC Press eBooks · doi:10.1201/9781420038798-6 · Cited by 1
Risco de Farmingham e evento cardiovascular em mulheres com síndrome dos ovários policísticos
Santos, A. G. (2014) · Americanae (AECID Library) · Cited by 1
Infertility and reproductive endocrinology
Bieber, E. J., Sanfilippo, J. S., Horowitz, I., & Shafi, M. I. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139628938.058 · Cited by 1
Effect of non-esterified fatty acids on insulin resistance and cardiovascular risk in polycystic ovary syndrome
Aye, M. M. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 1
Therapeutic Aspects of Polycystic Ovary Syndrome in Adolescence
Koliopoulos, C., & Creatsas, G. K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_27 · Cited by 1
Gonadotropinspiegel bei gesunden Frauen und PCOS-Patientinnen
Tauchert, S., Ludwig, A. K., Dietze, T., Diedrich, K., & Weiss, J. M. (2006) · Gynäkologische Endokrinologie · doi:10.1007/s10304-006-0153-x
The Molecular Basis of Insulin Action and Insulin Resistance
Avruch, J. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1597-5_8
The Psychopathology Changes in non-Obese PCOS Women Do Not Show any Influence on Neuropeptide Y Level
Yustina, M. (2016) · Indonesian Journal of Obstetrics and Gynecology · doi:10.32771/inajog.v36i3.310
Bestimmung der Fettgewebstopographie bei weiblichen und männlichen Sterilitätspatienten durch den Lipometer
Giuliani, A. L., Horejsi, R., Möller, R., & Tafeit, E. (2005) · Journal für Kardiologie (Krause & Pachernegg GmbH)

Authors: Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z.
Affiliations: Pennsylvania State University (US)
ORCID: Dunaif, A
Schenker, E
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1995-08-01
Volume: 96
Issue: 2
Pages: 801-810
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci118126
PMC: PMC185266
OpenAlex: W2124838987
Cited by: 561
References: 71
Citations by year: 2026: 3 · 2025: 15 · 2024: 7 · 2023: 17 · 2022: 20 · 2021: 18 · 2020: 15 · 2019: 6 · 2018: 9 · 2017: 13 · 2016: 8 · 2015: 19 · 2014: 18 · 2013: 23 · 2012: 21
FWCI: 18.65
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605, R01 DK-40605)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: polycystic ovary syndrome, insulin resistance, insulin receptor, serine phosphorylation, tyrosine phosphorylation, receptor autophosphorylation, protein tyrosine kinase activity, dermal fibroblasts, skeletal muscle, insulin signaling
MeSH terms: Adult, Blood Glucose, Cells, Cultured, Diabetes Mellitus, Type 2, Female, Fibroblasts, Humans, Insulin, Insulin Resistance, Obesity, Peptides, Phosphorylation, Phosphoserine, Polycystic Ovary Syndrome, Protein Processing, Post-Translational, Receptor, Insulin, Skin, Protein Serine-Threonine Kinases, Muscle, Skeletal, Intercellular Signaling Peptides and Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks